Abstract
Sprague-Dawley rats were treated with saline or turpentine oil (5μ 1/g bw sc at 3-day intervals ×3) with or without replacement doses of T4 (0.8 g/100 g bw/day ip) or T3(0.3 μg/100 g bw/day ip). Injection of turpentine oil to the rat consistently caused a significant reduction in serum total T4, total T3, free T4 index and TSH. Despite marked changes in thyroidal economy in experimental rat, iodothyronine 5′-monodeiodinating activity (MA) in the liver, the kidney and the hearth and the hepatic or-glycerophosphate dehydrogenase activity were decreased inconsistently and when decreased, the various enzyme activities were not influenced appreciably by treatment with replacement doses of T4 or T3. Cerebral cortical T4 5-MA was normal or increased in the turpentine oil-injected rat. Dermal T4 5-MA was decreased in the turpentine oil-injected rat and replacement doses of thyroid hormones did not normalize it. Urinary excretion of urea nitrogen was normal in the turpentine oil-injected rat and did not change appreciably after treatment with thyroid hormones. Our data suggest that replacement doses of thyroid hormones are not beneficial to a host with altered thyroid economy during a systemic illness.
Similar content being viewed by others
References
Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness: the “Euthyroid Sick Syndrome”. Endocr. Rev. 3: 164, 1982.
Chopra I.J., Hershman J.M., Pardridge W.D., Nicoloff J.T. Thyroid function in nonthyroid illness. Ann. Intern. Med. 98: 946, 1983.
Bermudez F., Surks M.I., Oppenheimer J.H. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroid disease. J. Clin. Endocrinol. Metab. 41: 27, 1975.
Kaplan M.M., Larsen P.R., Crantz F.R., Dzau V.J., Rossing T.H., Haddow J.E. Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am. J. Med. 72: 9, 1982.
Slag M.F., Morley J.E., Elson M.K., Crowson T.W., Nuttall F.Q., Shafer R.B. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245: 43, 1981.
Brent G.A., Hershman J.M. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J. Clin. Endocrinol. Metab. 63: 1, 1986.
Burman K.D., Wartofsky L., Dinterman R.E., Kesler P., Wannemacher R.W. The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion. Metabolism 28: 805, 1979.
Gardner D.F., Kaplan M.M., Stanley C.A., Utiger R.D. Effect of triiodothyronine replacement on the metabolic and pituitary responses to starvation. N. Engl. J. Med. 300: 579, 1979.
Chopra I.J. A study of extrathyroidal conversion of thyroxine to 3, 3′ 5-triiodothyronine (T3) in vitro. Endocrinology 101: 453, 1977.
Chopra I.J., Huang T.S., Hurd R.E., Solomon D.H. Effect of 3, 5, 3′-triiodothyronine-induced hyperthyroidism on iodothyronine metabolism in the rat: Evidence for tissue differences in metabolic responses. Endocrinology 114: 1454, 1984.
Huang T.S., Chopra I.J., Beredo A., Solomon D.H., Chua Teco G.N. Skin is an active site for the inner ring monodeiodination of thyroxine to 3, 3′, 5′-triiodothyronine. Endocrinology 117: 2106, 1985.
Huang T.S., Beredo A., Solomon D.H., Chopra I.J. The inner ring (5-) monodeiodination of thyroxine (T4) in cerebral cortex during fetal, neonatal and adult life. Metabolism 35: 272, 1986.
Lee Y.P., Lardy H.A. Influence of thyroid hormones on L-α-glycerophos-phate dehydrogenases and other dehydrogenases in various organs of the rat. J. Biol. Chem. 240: 1427, 1965.
Di Giorgio J. Nonprotein nitrogenous constituents. In: Henry R.J., Cannon D.C., Winkelman J.K. (Eds.), Clinical chemistry, principles and technics. Harper and Row Publishers, New York, 1974, p. 503.
Chopra I.J. A radioimmunoassay for measurement of thyroxine in unextracted serum. J. Clin. Endocrinol. Metab. 34: 938, 1972.
Chopra I.J. A radioimmunoassay of triiodothyronine in serum: Its application to clinical and physiological studies. J. Lab. Clin. Med. 80: 729, 1972.
Odell W.D., Wilber J.F., Utiger R.D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog. Horm. Res. 23: 47, 1967
Glantz S.A. Primer of biostatistics. McGraw-Hill Book Co., New York, 1981, p. 30.
Bacci V., Schussler G.C., Kaplan T.B. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J. Clin. Endocrinol. Metab. 54: 1229, 1982.
Savu L., Zouaghi H., Nunez E.A. Turpentine-induced decrease of alpha 1 -fetoprotein in the serum of the developing rat: a novel parameter of the inflammation response. Biochem. Biophys. Res. Commun. 110: 796, 1983.
Chopra I.J. Alterations in monodeiodination of iodothyronines in the fasting rat: Effects of reduced nonprotein sulfhydryl groups and hypothyroidism. Metabolism 29: 161, 1980.
Lim V.S., Henriquez C., Seo H., Refetoff S., Martino E. Thyroid function in a Uremic rat model: Evidence suggesting tissue hypothyroidism. J. Clin. Invest. 66: 946, 1980.
Grajower M.M., Surks M.I. Effect of decreased hepatic nuclear L-triiodothyronine receptors on the response of hepatic enzymes to L-triiodothyronine in tumor bearing rats. Endocrinology 104: 697, 1979.
Becker R.A., Vaughan G.M., Ziegler M.G., Seraile J.G., Goldfarb I.W., Mansour E.H., McManus W.F., Pruitt B.A., Mason A.D. Hypermetabolic low triiodothyronine syndrome of burn injury. Critical Care Med. 10: 870, 1982.
Little J.S. Effect of thyroid hormone supplementation on survival after bacterial infection. Endocrinology 117: 1431, 1985.
Palmer F.J., Nelson J.C. Replacement treatment of hypothyroidism. N. Engl. J. Med. 219: 101, 1974.
Hesch R.D., Husch M., Kodding R., Hoffken B., Meyer T. Treatment of dopamine-dependent shock with triiodothyronine. Endocr. Res. Commun. 8: 229, 1981.
Author information
Authors and Affiliations
Additional information
Supported by USPHS Grant AM16155 from the National Institute of Health, Bethesda, MD, USA.
Rights and permissions
About this article
Cite this article
Chopra, I.J., Huang, T.S., Boado, R. et al. Evidence against benefit from replacement doses of thyroid hormones in nonthyroidal illness (NTI): studies using turpentine oil-injected rat. J Endocrinol Invest 10, 559–564 (1987). https://doi.org/10.1007/BF03346994
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346994